Metropolitan Life Insurance CO Surmodics Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $3,477 - $7,819	-203 Reduced 20.71%	777 $17,000
Q4 2022 Jun 14, 2023	BUY	$29.44 - $37.31 $5,976 - $7,573	203 Added 26.13%	980 $33.4 Million
Q3 2022 Jun 14, 2023	BUY	$28.84 - $38.92 $5,854 - $7,900	203 Added 26.13%	980 $29.8 Million
Q2 2022 Jun 20, 2023	BUY	$33.25 - $45.11 $6,749 - $9,157	203 Added 26.13%	980 $36,000
Q1 2022 Jun 20, 2023	BUY	$40.68 - $49.72 $8,258 - $10,093	203 Added 26.13%	980 $44,000
Q1 2022 Mar 30, 2023	SELL	$40.68 - $49.72 $112,195 - $137,127	-2,758 Reduced 73.78%	980 $44,000
Q1 2022 May 12, 2022	SELL	$40.68 - $49.72 $112,195 - $137,127	-2,758 Reduced 73.78%	980 $44,000
Q4 2021 Jun 21, 2023	BUY	$43.21 - $57.6 $127,944 - $170,553	2,961 Added 381.08%	3,738 $179,000
Q3 2021 Jun 21, 2023	BUY	$52.8 - $60.32 $156,340 - $178,607	2,961 Added 381.08%	3,738 $207,000
Q3 2021 Mar 30, 2023	SELL	$52.8 - $60.32 $43,032 - $49,160	-815 Reduced 17.9%	3,738 $207,000
Q3 2021 Nov 15, 2021	SELL	$52.8 - $60.32 $43,032 - $49,160	-815 Reduced 17.9%	3,738 $208,000
Q2 2021 Jun 21, 2023	BUY	$51.29 - $59.15 $193,671 - $223,350	3,776 Added 485.97%	4,553 $247,000
Q2 2021 Mar 30, 2023	BUY	$51.29 - $59.15 $16,515 - $19,046	322 Added 7.61%	4,553 $247,000
Q2 2021 Aug 16, 2021	BUY	$51.29 - $59.15 $233,318 - $269,073	4,549 Added 113725.0%	4,553 $247,000
Q1 2021 Jun 26, 2023	BUY	$42.18 - $56.07 $145,689 - $193,665	3,454 Added 444.53%	4,231 $237 Million
Q1 2021 Mar 30, 2023	SELL	$42.18 - $56.07 $12,063 - $16,036	-286 Reduced 6.33%	4,231 $237,000
Q1 2021 May 14, 2021	SELL	$42.18 - $56.07 $190,358 - $253,043	-4,513 Reduced 99.91%	4 $237,000
Q4 2020 Jun 22, 2023	BUY	$35.18 - $43.52 $131,573 - $162,764	3,740 Added 481.34%	4,517 $196,000
Q3 2020 Jun 26, 2023	BUY	$37.98 - $48.72 $142,045 - $182,212	3,740 Added 481.34%	4,517 $175,000
Q2 2020 Jun 26, 2023	BUY	$31.07 - $44.74 $116,201 - $167,327	3,740 Added 481.34%	4,517 $195,000
Q1 2020 Jul 12, 2023	BUY	$22.46 - $42.24 $84,000 - $157,977	3,740 Added 481.34%	4,517 $150,000
Q4 2019 Jul 12, 2023	BUY	$39.01 - $47.51 $145,897 - $177,687	3,740 Added 481.34%	4,517 $187,000
Q3 2019 Jul 12, 2023	BUY	$38.66 - $47.41 $144,588 - $177,313	3,740 Added 481.34%	4,517 $206,000
Q2 2019 Jul 12, 2023	BUY	$38.23 - $47.43 $142,980 - $177,388	3,740 Added 481.34%	4,517 $194,000
Q1 2019 Jul 13, 2023	BUY	$41.26 - $58.35 $154,312 - $218,229	3,740 Added 481.34%	4,517 $196,000
Q1 2019 Mar 30, 2023	BUY	$41.26 - $58.35 $145,936 - $206,383	3,537 Added 360.92%	4,517 $196,000
Q1 2019 May 16, 2019	SELL	$41.26 - $58.35 $499,452 - $706,326	-12,105 Reduced 72.83%	4,517 $196,000
Q1 2019 May 15, 2019	BUY	$41.26 - $58.35 $499,452 - $706,326	12,105 Added 267.99%	16,622 $589,000
Q4 2018 Jul 13, 2023	BUY	$44.93 - $73.38 $168,038 - $274,441	3,740 Added 481.34%	4,517 $213,000
Q4 2018 Feb 14, 2019	BUY	$44.93 - $73.38 $160,534 - $262,186	3,573 Added 378.5%	4,517 $213,000
Q3 2018 Jul 13, 2023	BUY	$56.85 - $80.35 $212,619 - $300,509	3,740 Added 481.34%	4,517 $337 Million
Q3 2018 Nov 14, 2018	SELL	$56.85 - $80.35 $221,999 - $313,766	-3,905 Reduced 80.53%	944 $70,000
Q4 2017 Feb 15, 2018	SELL	$28.0 - $33.2 $124,656 - $147,806	-4,452 Reduced 47.87%	4,849 $136,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,301	9,301 $262,000

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

11.7M

Call Options Held

1.4K

Put Options Held

8.6K

Black Rock Inc. New York, NY

1.17M
Shares

$39.9 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

1.04M
Shares

$35.4 Million
0.01% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

989K
Shares

$33.7 Million
14.09% of portfolio
Vanguard Group Inc Valley Forge, PA

804K
Shares

$27.4 Million
0.0% of portfolio
Morgan Stanley New York, NY

753K
Shares

$25.6 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $477M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account